CA 125: Reference Range | 合法醫療器材資訊網

2020年1月10日—CA125istheonlytumormarkerrecommendedforclinicaluseinthediagnosisandmanagementofovariancancer.ThereferencerangeofCA ...

Up to 80% of women with ovarian carcinoma[1] of epithelial origin have elevated serum CA 125 levels, with the frequency of elevation correlating with the clinically detected stage. [3] The degree of elevation has also been shown to correlate with tumor burden and International Federation of Obstetrics and Gynecologic (FIGO) pathologic stage. However, owing to the lack of sensitivity and specificity, elevations in single or sequential CA 125 levels alone are not recommended for ovarian cancer screening or in the initial diagnosis of ovarian cancer. [4, 5] CA 125 levels may also be elevated in other malignancies, as well as in benign and physiologic conditions.

Malignant conditions associated with elevated CA 125 levels include the following:

Benign conditions associated with elevated CA 125 levels include the following:

Owing to the heterogeneity of its dis...